Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson's Disease.

Biomolecules - 16 Jun 2020

Polissidis Alexia, Petropoulou-Vathi Lilian, Nakos-Bimpos Modestos, Rideout Hardy J

Abstract excerpt

Biomarkers and disease-modifying therapies are both urgent unmet medical needs in the treatment of Parkinson's disease (PD) and must be developed concurrently because of their interdependent relationship: biomarkers for the early detection of disease (i.e., prior to overt neurodegeneration) are necessary in order for patients to receive maximal therapeutic benefit and vice versa; disease-modifying therapies must...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Genetic Heterogeneity
Share to Genetic Therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to History, 21st Century

Share to Molecular Targeted Therapy

Share to Mutation

Share to Parkinson Disease

Share to Parkinson's Disease Mechanisms and Treatments

Source

Open in PubMed Open full text

Identifiers

PMID: 32560161
DOI: 10.3390/biom10060912
PMCID: PMC7355671

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson's Disease.PMID 32560161Read ↗

Pathological Protein Targets in Parkinson's Disease: Progress Towards the Development of Disease-Modifying Therapies.Semantic proximity Read ↗

An update on the monogenic causes of Parkinson's disease: Impact on patient stratification and personalised medicine.Semantic proximity Read ↗

Parkinson's Disease: From Gene-Environment Risk to Precision Therapy.Semantic proximity Read ↗

Updates on the Genetics of Parkinson's Disease: Clinical Implications and Future Treatment.Semantic proximity Read ↗

Precision medicine in Parkinson's disease patients with LRRK2 and GBA risk variants - Let's get even more personal.Semantic proximity Read ↗

Translating genetic findings into therapy in Parkinson disease.Semantic proximity Read ↗

GBA1-and LRRK2-directed Treatments: The Way Forward.Semantic proximity Read ↗

Parkinson’s Disease: From Gene–Environment Risk to Precision TherapySemantic proximity Read ↗

The genetic background of Parkinson's disease and novel therapeutic targets.Semantic proximity Read ↗

Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism.Semantic proximity Read ↗

Genetics of Parkinson's Disease: From Causes to Treatment.Semantic proximity Read ↗

Genetics and genomics of Parkinson’s diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.